MedTrace Logo

China Alair System Registry Study-CARE Study

NCT02206269 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2018-02-23

No results posted yet for this study

Summary

The objective of this Registry is to collect real-world outcome data for bronchial thermoplasty (BT) procedures in patients with severe persistent asthma who remain symptomatic despite taking standard of care maintenance medications.

Conditions

Interventions

DEVICE

Alair System

The Alair system is used for doing bronchial thermoplasty.

Sponsors & Collaborators

  • BSC International Medical Trading (Shanghai) Co., Ltd.

    lead OTHER

Principal Investigators

  • Jiangtao Lin, Professor · China-Japan Friendship Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2018-12-31
Completion
2019-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02206269 on ClinicalTrials.gov